{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:39:38Z","timestamp":1761241178693,"version":"build-2065373602"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is associated with altered hypothalamic-pituitary-ovarian function, which may affect the success of GnRH agonist triggers used during IVF. Identifying reliable predictors of oocyte yield in these patients remains a clinical challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate possible predictors of suboptimal oocyte retrieval per aspirated follicle when ovulation is triggered with GnRH agonist in PCOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 30\/04\/2021 and 30\/12\/2022, a prospective cohort study was conducted among women with PCOS (n\u2009=\u2009104) in which a GnRH agonist trigger was employed during a GnRH antagonist protocol. Hormonal and clinical parameters were tested for their ability to predict the oocyte per aspirated follicle (OPF) rate in in-vitro fertilization (IVF) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of the patients, mean number of aspirated follicles, number of collected oocyte cumulus complexes and OPF were 28.6\u2009\u00b1\u20093.9 years, 31.4\u2009\u00b1\u200910.2, 21.7\u2009\u00b1\u20098.9, and 70.2\u2009\u00b1\u200919.1%, respectively. When patients were stratified into three groups according to their OPF percentiles (Q1:0\u201325th percentile, Q2:26\u201375th percentile, Q3:76\u2013100th percentile), body mass index (BMI) and antral follicle count (AFC) were significantly higher in the Q1 group compared to the Q2 and Q3 groups. However, regression analysis revealed that only AFC was an independent predictor of the OPF rate (RR: \u22120.005, 95% CI: \u22120.008 to \u22120.002, p\u2009=\u20090.001), but not BMI or serum LH levels on the day of triggering. Notably, the predictive validity of AFC to recognize a low OPF rate was poor (AUC\u2009=\u20090.561).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A high AFC was the only identifiable predictor of the OPF rate and a suboptimal response when a GnRH agonist trigger was used for final follicular maturation. However, since a low AUC for AFC suggests a poor performance, we conclude that this study was not able to find any reliable prediction markers for the OPF rate in PCOS patients triggered with GnRHa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0332813","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:33:43Z","timestamp":1761240823000},"page":"e0332813","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Limitations of hormonal and clinical markers in predicting GnRH agonist trigger success in polycystic ovary syndrome: A critical reappraisal"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-2786","authenticated-orcid":true,"given":"Fazilet Kubra","family":"Boynukalin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zalihe","family":"Yark\u0131ner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Gultomruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozkan","family":"Ozdamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurkan","family":"Bozdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"3","key":"pone.0332813.ref001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00016347309158325","article-title":"\u201cTriggering\u201d of ovulation after infusion of synthetic luteinizing hormone releasing factor (LRF)","volume":"52","author":"R Nakano","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"pone.0332813.ref002","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","article-title":"Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication","volume":"15","author":"J Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"issue":"5","key":"pone.0332813.ref003","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"P Humaidan","year":"2005","journal-title":"Hum Reprod"},{"issue":"10","key":"pone.0332813.ref004","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"EM Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"issue":"10","key":"pone.0332813.ref005","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"P Devroey","year":"2011","journal-title":"Hum Reprod"},{"issue":"10","key":"pone.0332813.ref006","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"2014","author":"MAFM Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"pone.0332813.ref007","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.06.013","article-title":"Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response","volume":"106","author":"FE Chang","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"pone.0332813.ref008","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"S-L Chen","year":"2012","journal-title":"Hum Reprod"},{"issue":"3","key":"pone.0332813.ref009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.fertnstert.2015.06.011","article-title":"Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles","volume":"104","author":"L Meyer","year":"2015","journal-title":"Fertil Steril"},{"issue":"10","key":"pone.0332813.ref010","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/dez132","article-title":"Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation","volume":"34","author":"B Popovic-Todorovic","year":"2019","journal-title":"Hum Reprod"},{"issue":"5","key":"pone.0332813.ref011","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0015-0282(16)54678-0","article-title":"What is the true follicular diameter: an assessment of the reproducibility of transvaginal ultrasound monitoring in stimulated cycles","volume":"56","author":"RG Forman","year":"1991","journal-title":"Fertil Steril"},{"issue":"1","key":"pone.0332813.ref012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humrep\/deq320","article-title":"Comparison of automated and manual follicle monitoring in an unrestricted population of 100 women undergoing controlled ovarian stimulation for IVF","volume":"26","author":"B Ata","year":"2011","journal-title":"Hum Reprod"},{"issue":"7","key":"pone.0332813.ref013","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/clinem\/dgad026","article-title":"Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea","volume":"108","author":"A Abbara","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"pone.0332813.ref014","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome\u2020","volume":"38","author":"HJ Teede","year":"2023","journal-title":"Hum Reprod"},{"issue":"4","key":"pone.0332813.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176019","article-title":"Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles","volume":"12","author":"V Gunnala","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"pone.0332813.ref016","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJM198803033180906","article-title":"Pathogenesis and Treatment of Polycystic Ovary Syndrome","volume":"318","author":"TJ McKenna","year":"1988","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0332813.ref017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"RL Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"2","key":"pone.0332813.ref018","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"N Massin","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"1","key":"pone.0332813.ref019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humupd\/dmi030","article-title":"Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review","volume":"12","author":"EM Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"4","key":"pone.0332813.ref020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"BC Tarlatzis","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"3","key":"pone.0332813.ref021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-M\u00fcllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"VK Genro","year":"2011","journal-title":"Hum Reprod"},{"issue":"2","key":"pone.0332813.ref022","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-M\u00fcllerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"R Fanchin","year":"2003","journal-title":"Hum Reprod"},{"issue":"1","key":"pone.0332813.ref023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","article-title":"Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome","volume":"17","author":"K Keane","year":"2017","journal-title":"Reprod Biol"},{"issue":"5","key":"pone.0332813.ref024","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/humrep\/deae041","article-title":"Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering","volume":"39","author":"S Gambini","year":"2024","journal-title":"Hum Reprod"},{"issue":"5","key":"pone.0332813.ref025","first-page":"742","article-title":"Predictors of IVF success","volume":"121","author":"L Shingshetty","year":"2024","journal-title":"Fertil Steril"},{"key":"pone.0332813.ref026","doi-asserted-by":"crossref","first-page":"1216584","DOI":"10.3389\/fendo.2023.1216584","article-title":"The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger","volume":"14","author":"WH-Y Lee","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:33:47Z","timestamp":1761240827000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332813"}},"subtitle":[],"editor":[{"given":"Wan-Xi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332813","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}